|
SPEN expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.326000E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.532200E-01 |
| Normal-vs-Stage2 |
3.587400E-01 |
| Normal-vs-Stage3 |
2.576300E-02 |
| Normal-vs-Stage4 |
6.819200E-03 |
| Stage1-vs-Stage2 |
1.443610E-01 |
| Stage1-vs-Stage3 |
7.773400E-04 |
| Stage1-vs-Stage4 |
2.579700E-04 |
| Stage2-vs-Stage3 |
5.164200E-01 |
| Stage2-vs-Stage4 |
2.918600E-01 |
| Stage3-vs-Stage4 |
5.241600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.010200E-01 |
| Normal-vs-AfricanAmerican |
5.191000E-01 |
| Normal-vs-Asian |
4.259800E-01 |
| Caucasian-vs-AfricanAmerican |
9.548400E-01 |
| Caucasian-vs-Asian |
2.040200E-01 |
| AfricanAmerican-vs-Asian |
2.566400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.248100E-02 |
| Normal-vs-Female |
2.809600E-01 |
| Male-vs-Female |
5.799700E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.103400E-01 |
| Normal-vs-Age(41-60Yrs) |
8.856000E-01 |
| Normal-vs-Age(61-80Yrs) |
2.051800E-01 |
| Normal-vs-Age(81-100Yrs) |
3.091200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.122200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.185400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.960200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.925840E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.678000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.229000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.457630E-02 |
| Normal-vs-Grade 2 |
4.121200E-01 |
| Normal-vs-Grade 3 |
5.806300E-02 |
| Normal-vs-Grade 4 |
4.33290000000364E-05 |
| Grade 1-vs-Grade 2 |
1.583180E-03 |
| Grade 1-vs-Grade 3 |
2.2580999999966E-05 |
| Grade 1-vs-Grade 4 |
1.020180E-03 |
| Grade 2-vs-Grade 3 |
2.661200E-03 |
| Grade 2-vs-Grade 4 |
8.07810000003073E-08 |
| Grade 3-vs-Grade 4 |
9.684800E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.150350E-02 |
| Normal-vs-ccB subtype |
4.412800E-04 |
| ccA subtype-vs-ccB subtype |
1.05199959854474E-10 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.071200E-01 |
| Normal-vs-N1 |
7.396400E-02 |
| N0-vs-N1 |
3.544000E-01 |
|
|
